<DOC>
	<DOCNO>NCT00003911</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Stereotactic radiosurgery may kill tumor cell . PURPOSE : Phase II trial study effectiveness radiation therapy follow stereotactic radiosurgery treat patient brain metastasis malignant melanoma .</brief_summary>
	<brief_title>S9903 : Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery Limited Malignant Melanoma Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate 6 month intracranial progression rate 6 month overall survival rate patient limit brain metastasis malignant melanoma undergoing whole brain radiotherapy follow stereotactic radiosurgery boost . II . Evaluate qualitative quantitative toxic effect regimen patient . OUTLINE : Patients undergo whole brain radiotherapy 5 day week 3 week , follow 3-5 week later stereotactic radiosurgery . Patients follow every 3 month death . PROJECTED ACCRUAL : A total 60 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove malignant melanoma primary metastatic site Bidimensionally measurable disease MRI scan Must 16 enhance brain metastasis If least 2 lesion present , 1 lesion may great 3 cm maximum diameter PATIENT CHARACTERISTICS : Age : Not specify Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic response modifier immunotherapy Chemotherapy : No concurrent chemotherapy whole brain radiotherapy Prior systemic chemotherapy allow Endocrine therapy : Not specify Radiotherapy : No prior stereotactic conventional radiotherapy field brain Surgery : Prior surgical resection brain metastasis allow ( provide 1 2 measurable brain metastasis remain )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>tumor metastatic brain</keyword>
</DOC>